Pulmonary Fibrosis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Could Pulmonary Fibrosis Life Be Giving Me Anxiety? - Pulmonary Fibrosis News



Pulmonary Fibrosis News
 
Could Pulmonary Fibrosis Life Be Giving Me Anxiety? 
Pulmonary Fibrosis News
Columnist Charlene Marshall reflects on her past misconceptions of anxiety and wonders if she's experiencing symptoms of it.
Azithromycin: A New Treatment Hope for Idiopathic Pulmonary Fibrosis? Medscape
Global Idiopathic Pulmonary Fibrosis Sales market Research Report ... Tokenfolks (press release)

all 3 news articles » 


PMD Healthcare Creating Pulmonary Fibrosis Patient Advisory Board - Pulmonary Fibrosis News



Pulmonary Fibrosis News
 
PMD Healthcare Creating Pulmonary Fibrosis Patient Advisory Board 
Pulmonary Fibrosis News
PMD Healthcare is creating advisory boards composed of pulmonary fibrosis and cystic fibrosis patients and caregivers. The company, whose services include remote monitoring of patients' health conditions, is in the midst of recruiting members of both ...

 


Idiopathic Pulmonary Fibrosis Pipeline Highlights - 2017-2020 Update - ResearchAndMarkets.com - Business Wire (press release)



Idiopathic Pulmonary Fibrosis Pipeline Highlights - 2017-2020 Update - ResearchAndMarkets.com 
Business Wire (press release)
The latest report from, Idiopathic Pulmonary Fibrosis Pipeline Highlights - 2017 Update, provides most up-to-date information on key pipeline products in the global Idiopathic Pulmonary Fibrosis market. It covers emerging therapies for Idiopathic ...

and more » 


Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada - Dove Medical Press



Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada 
Dove Medical Press
1Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada; 2Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe's Hamilton, St. Joseph's ...

 


The Gift of Quiet Weekends - Pulmonary Fibrosis News



Pulmonary Fibrosis News
 
The Gift of Quiet Weekends 
Pulmonary Fibrosis News
If you have read my previous columns, you are likely aware that my life before being diagnosed with idiopathic pulmonary fibrosis (IPF) was very different than it is now. This is something I often write about because I can't believe the dramatic ...

 


The Invisible Impact of Trauma on Pulmonary Fibrosis Patients - Lung Disease News



The Invisible Impact of Trauma on Pulmonary Fibrosis Patients 
Lung Disease News
With the exception of using supplemental oxygen, pulmonary fibrosis (PF) is an invisible disease for the most part. Like other chronic illnesses, it can be extremely difficult for patients to deal with; others can't understand many of the physical ...

 


Enzyme Can Start Process That Leads to Tissue Scarring Being Reversed, Study Shows - Pulmonary Fibrosis News



Pulmonary Fibrosis News
 
Enzyme Can Start Process That Leads to Tissue Scarring Being Reversed, Study Shows 
Pulmonary Fibrosis News
Fibrosis is the excessive growth, hardening, or scarring of connective tissue due to inflammation. It can cause permanent organ damage and chronic diseases such as pulmonary and cardiac fibrosis, asthma, atherosclerosis, cirrhosis, and scleroderma ...

 


Telomerase Gene Therapy Cures Pulmonary Fibrosis in Mice - Genetic Engineering & Biotechnology News



Telomerase Gene Therapy Cures Pulmonary Fibrosis in Mice 
Genetic Engineering & Biotechnology News
Pulmonary fibrosis is a fatal lung condition that can be associated with lung cells exhibiting short telomeres, the protective structures at the ends of chromosomes. Researchers in Spain now report on the use of an adeno-associated virus (AAV) vector ...

 


Kadmon Therapy Slows Progression of Pulmonary Fibrosis, Phase 2 Trial Shows - Pulmonary Fibrosis News



Pulmonary Fibrosis News
 
Kadmon Therapy Slows Progression of Pulmonary Fibrosis, Phase 2 Trial Shows 
Pulmonary Fibrosis News
Kadmon's KD025 slowed the progression of idiopathic pulmonary fibrosis and patients' decline in lung function, a Phase 2 clinical trial shows. The IPF patients in the open-label trial (NCT02688647) had previously been treated with Genentech's Esbriet ...

 


Prometic's PBI-4050 Plays Dual Role in Targeting New Antifibrotic Pathway, Study Says - Pulmonary Fibrosis News



Pulmonary Fibrosis News
 
Prometic's PBI-4050 Plays Dual Role in Targeting New Antifibrotic Pathway, Study Says 
Pulmonary Fibrosis News
Therefore, by targeting this novel antifibrotic pathway, PBI-4050 and its analogues have the potential to delay or even reverse the progression of fibrotic diseases,? Gagnon said. The benefits of PBI-4050 seen in animal models also were demonstrated in ...